These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 1402395)

  • 41. Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides.
    Haltia A; Solin ML; Jalanko H; Holmberg C; Miettinen A; Holthöfer H
    Histochem J; 1996 Oct; 28(10):681-7. PubMed ID: 8950597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.
    Cohen T; Auerbach W; Ravid L; Bodennec J; Fein A; Futerman AH; Joyner AL; Horowitz M
    Mol Cell Biol; 2005 Mar; 25(6):2431-40. PubMed ID: 15743835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of prosaposin in the male reproductive system: effect of prosaposin inactivation on the testis, epididymis, prostate, and seminal vesicles.
    Morales CR; Zhao Q; Lefrancois S; Ham D
    Arch Androl; 2000; 44(3):173-86. PubMed ID: 10864364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding of cerebrosides and sulfatides to saposins A-D.
    Soeda S; Hiraiwa M; O'Brien JS; Kishimoto Y
    J Biol Chem; 1993 Sep; 268(25):18519-23. PubMed ID: 8360153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activator proteins and topology of lysosomal sphingolipid catabolism.
    Fürst W; Sandhoff K
    Biochim Biophys Acta; 1992 Jun; 1126(1):1-16. PubMed ID: 1606169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The primary structure of mouse saposin.
    Tsuda M; Sakiyama T; Endo H; Kitagawa T
    Biochem Biophys Res Commun; 1992 May; 184(3):1266-72. PubMed ID: 1590788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural and membrane-binding properties of saposin D.
    Tatti M; Salvioli R; Ciaffoni F; Pucci P; Andolfo A; Amoresano A; Vaccaro AM
    Eur J Biochem; 1999 Jul; 263(2):486-94. PubMed ID: 10406958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular role of sulfated glycoprotein-1 (SGP-1/prosaposin) in Sertoli cells.
    Morales CR; el-Alfy M; Zhao Q; Igdoura S
    Histol Histopathol; 1995 Oct; 10(4):1023-34. PubMed ID: 8573994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of mouse sulfated glycoprotein-1 (prosaposin) in the testis and other tissues.
    Morales CR; Hay N; El-Alfy M; Zhao Q
    J Androl; 1998; 19(2):156-64. PubMed ID: 9570738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteolytic processing patterns of prosaposin in insect and mammalian cells.
    Leonova T; Qi X; Bencosme A; Ponce E; Sun Y; Grabowski GA
    J Biol Chem; 1996 Jul; 271(29):17312-20. PubMed ID: 8663398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of saposin proteins (sphingolipid activator proteins) in human tissues.
    Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
    Anal Biochem; 1990 Nov; 190(2):154-7. PubMed ID: 2127157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of prosaposin as a neurotrophic factor.
    O'Brien JS; Carson GS; Seo HC; Hiraiwa M; Kishimoto Y
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9593-6. PubMed ID: 7937812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distribution of prosaposin-like immunoreactivity in rat brain.
    Kondoh K; Sano A; Kakimoto Y; Matsuda S; Sakanaka M
    J Comp Neurol; 1993 Aug; 334(4):590-602. PubMed ID: 8408767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K; Kolter T
    Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Saposins (sap) A and C activate the degradation of galactosylceramide in living cells.
    Harzer K; Paton BC; Christomanou H; Chatelut M; Levade T; Hiraiwa M; O'Brien JS
    FEBS Lett; 1997 Nov; 417(3):270-4. PubMed ID: 9409731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies.
    Chatelut M; Harzer K; Christomanou H; Feunteun J; Pieraggi MT; Paton BC; Kishimoto Y; O'Brien JS; Basile JP; Thiers JC; Salvayre R; Levade T
    Clin Chim Acta; 1997 Jun; 262(1-2):61-76. PubMed ID: 9204210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. pH-dependent conformational properties of saposins and their interactions with phospholipid membranes.
    Vaccaro AM; Ciaffoni F; Tatti M; Salvioli R; Barca A; Tognozzi D; Scerch C
    J Biol Chem; 1995 Dec; 270(51):30576-80. PubMed ID: 8530492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Saposin A: second cerebrosidase activator protein.
    Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and tissue distribution of rat sulfated glycoprotein-1 (prosaposin).
    Morales CR; El-Alfy M; Zhao Q; Igdoura SA
    J Histochem Cytochem; 1996 Apr; 44(4):327-37. PubMed ID: 8601692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation.
    Hulková H; Cervenková M; Ledvinová J; Tochácková M; Hrebícek M; Poupetová H; Befekadu A; Berná L; Paton BC; Harzer K; Böör A; Smíd F; Elleder M
    Hum Mol Genet; 2001 Apr; 10(9):927-40. PubMed ID: 11309366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.